226 related articles for article (PubMed ID: 8558645)
21. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
22. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
Li CC; Chang TH; Wu WJ; Ke HL; Huang SP; Tsai PC; Chang SJ; Shen JT; Chou YH; Huang CH
Eur Urol; 2008 Nov; 54(5):1127-34. PubMed ID: 18243511
[TBL] [Abstract][Full Text] [Related]
23. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.
Stein JP; Clark P; Miranda G; Cai J; Groshen S; Skinner DG
J Urol; 2005 Apr; 173(4):1163-8. PubMed ID: 15758728
[TBL] [Abstract][Full Text] [Related]
24. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
Hassan JM; Cookson MS; Smith JA; Johnson DL; Chang SS
J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
26. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
[TBL] [Abstract][Full Text] [Related]
27. Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy.
Lee SE; Byun SS; Hong SK; Chang IH; Kim YJ; Gill MC; Song SH; Kim KT
Urol Int; 2006; 77(1):13-7. PubMed ID: 16825809
[TBL] [Abstract][Full Text] [Related]
28. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder.
Westney OL; Pisters LL; Pettaway CA; Tu SM; Pollack A; Dinney CP
J Urol; 1998 Mar; 159(3):792-5. PubMed ID: 9474150
[TBL] [Abstract][Full Text] [Related]
29. Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center.
Akkad T; Gozzi C; Deibl M; Müller T; Pelzer AE; Pinggera GM; Bartsch G; Steiner H
J Urol; 2006 Apr; 175(4):1268-71; discussion 1271. PubMed ID: 16515977
[TBL] [Abstract][Full Text] [Related]
30. Management of superficial transitional cell carcinoma in the intramural ureter: what to do?
Palou J; Salvador J; Millán F; Collado A; Algaba F; Vicente J
J Urol; 2000 Mar; 163(3):744-7. PubMed ID: 10687968
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
Koda S; Mita K; Shigeta M; Usui T
Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
[TBL] [Abstract][Full Text] [Related]
32. [An analysis of upper urinary tract recurrence following radical cystectomy for bladder cancer].
Sugi M; Fukui K; Yoshida K; Inui H; Kawakita S; Murota T; Kinoshita H; Matsuda T
Hinyokika Kiyo; 2010 Feb; 56(2):87-90. PubMed ID: 20185992
[TBL] [Abstract][Full Text] [Related]
33. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
34. Stenting Prior to Cystectomy is an Independent Risk Factor for Upper Urinary Tract Recurrence.
Kiss B; Furrer MA; Wuethrich PY; Burkhard FC; Thalmann GN; Roth B
J Urol; 2017 Dec; 198(6):1263-1268. PubMed ID: 28603003
[TBL] [Abstract][Full Text] [Related]
35. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
36. Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management.
Solsona E; Iborra I; Ricós JV; Dumont R; Casanova JL; Calabuig C
Urology; 1997 Mar; 49(3):347-52. PubMed ID: 9123696
[TBL] [Abstract][Full Text] [Related]
37. The prognostic predictors of primary ureteral transitional cell carcinoma after radical nephroureterectomy.
Li WM; Li CC; Ke HL; Wu WJ; Huang CN; Huang CH
J Urol; 2009 Aug; 182(2):451-8; discussion 458. PubMed ID: 19524962
[TBL] [Abstract][Full Text] [Related]
38. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center.
Chen ME; Pisters LL; Malpica A; Pettaway CA; Dinney CP
J Urol; 1997 Jun; 157(6):2120-3. PubMed ID: 9146596
[TBL] [Abstract][Full Text] [Related]
39. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
Sadek S; Soloway MS; Hook S; Civantos F
J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
Soga N; Arima K; Sugimura Y
Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
